We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLDO
5176
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$125K ﹤0.01%
+13,778
New +$113K
LOMA
5177
Loma Negra
LOMA
$1.29B
$124K ﹤0.01%
20,199
-13,559
-40% -$69.7K
SFE
5178
DELISTED
Safeguard Scientifics, Inc.
SFE
$124K ﹤0.01%
19,394
-39,737
-67% -$248K
EPIX
5179
DELISTED
ESSA Pharma
EPIX
$123K ﹤0.01%
+10,284
New +$72.4K
LSAK icon
5180
Lesaka Technologies
LSAK
$408M
$123K ﹤0.01%
24,964
-11,357
-31% -$39.7K
LYRA
5181
DELISTED
LYRA THERAPEUTICS INC
LYRA
$123K ﹤0.01%
+217
New +$122K
APRN
5182
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$122K ﹤0.01%
1,817
-3,430
-65% -$266K
CODA icon
5183
Coda Octopus Group
CODA
$119M
$121K ﹤0.01%
19,265
-963
-5% -$5.67K
ORKA
5184
Oruka Therapeutics
ORKA
$5.88B
$121K ﹤0.01%
+2,525
New +$126K
JT
5185
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$120K ﹤0.01%
39,364
-4
-0% -$14
ONCS
5186
DELISTED
OncoSec Medical Incorporated
ONCS
$120K ﹤0.01%
845
+17
+2% +$1.81K
KBNT
5187
DELISTED
Kubient, Inc. Common Stock
KBNT
$119K ﹤0.01%
+21,258
New +$87.9K
AMC icon
5188
AMC Entertainment Holdings
AMC
$2.3B
$118K ﹤0.01%
5,573
-12,930
-70% -$423K
AVCTW
5189
DELISTED
American Virtual Cloud Technologies, Inc. Warrant expiring 4/7/2025
AVCTW
$118K ﹤0.01%
250,000
SMED
5190
DELISTED
Sharps Compliance Corp
SMED
$118K ﹤0.01%
+12,458
New +$95.3K
NUVB icon
5191
Nuvation Bio
NUVB
$2.14B
$117K ﹤0.01%
+10,000
New +$104K
LEAF
5192
DELISTED
Leaf Group Ltd.
LEAF
$117K ﹤0.01%
25,232
+10,135
+67% +$55.9K
COGT icon
5193
Cogent Biosciences
COGT
$7.07B
$116K ﹤0.01%
10,313
+2,188
+27% +$24K
QUMU
5194
DELISTED
Qumu Corp.
QUMU
$116K ﹤0.01%
+14,543
New +$76.6K
NEXT icon
5195
NextDecade
NEXT
$1.82B
$115K ﹤0.01%
54,931
+1,248
+2% +$3.17K
LUNA
5196
DELISTED
Luna Innovations Incorporated
LUNA
$115K ﹤0.01%
11,686
+1,022
+10% +$8.15K
TRVG
5197
trivago
TRVG
$393M
$114K ﹤0.01%
9,383
-30,923
-77% -$272K
CRESY
5198
Cresud
CRESY
$773M
$113K ﹤0.01%
+24,507
New +$85.9K
FENG
5199
Phoenix New Media
FENG
$17.8M
$113K ﹤0.01%
15,716
+1,294
+9% +$13.6K
CYCN icon
5200
Cyclerion Therapeutics
CYCN
$17.2M
$112K ﹤0.01%
1,840
+1,106
+151% +$75.4K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.